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4Abstract
Much research effort is being directed towards the development of bone tissue engineering 
techniques as alternatives to grafts for the treatment of bone defects. A major challenge is that 
following implantation of the tissue engineered construct, inadequate vascularity limits the 
supply of nutrients to the proliferating osteoprogenitor cells within the scaffolding. One 
proposed means of addressing this issue is the addition of endothelial cells (EC), major 
components of vessel-formation, to bone marrow stromal cells (MSC) seeded onto a 
biodegradable scaffold. The aim of the present series of studies was to investigate interactions 
between endothelial cells and bone marrow stromal cells, with special reference to osteogenic 
differentiation of MSC and bone formation.    
         In study I, the addition of EC to MSC at a ratio of 1:5 resulted in significant increases in 
cell proliferation and cellular bridges between the two cell types. At the same time, increased 
mRNA expression of alkaline phosphatase was observed; this effect was greater than that 
achieved by the addition of osteogenic factors such as dexamethasone, ascorbic acid and -
glycerophosphate to the culture medium. This interesting finding suggests that under 
conditions of direct contact culturing, endothelial cells influence the osteogenic differentiation 
of MSC. 
         Study II was designed to select an appropriate copolymer scaffold to support the cells 
during the initial stages. MSC were seeded onto two porous test scaffolds, made of poly(LLA-
co-CL) and poly(LLA-co-DXO). The cellular response was determined in terms of 
attachment, proliferation and differentiation. The results showed that poly(LLA-co-CL) and 
poly(LLA-co-DXO) promoted better cell attachment and growth than the control scaffolding, 
poly(LLA). Moreover, MSC retained their osteogenic differentiation potential on the 
scaffolds.  
5         As shown in study I, EC influenced the osteogenic differentiation of MSC. In study III, 
this effect was investigated in vivo, using a rat calvarial bone defect model to compare bone 
regeneration by MSC grown in mono- or co-culture. Either bone marrow stromal cells alone 
(MSC-group) or both types of cell (CO-group) were seeded onto poly(LLA-co-DXO) 
scaffolds, cultured in spinner flasks and then implanted into symmetrical calvarial defects. 
After two months, new bone and vessel formation were evaluated by radiography and 
histology and expression of osteogenic markers by RT-PCR. Bone formation was more rapid 
in the CO- than in the MSC-group, but no significant differences were detected with respect 
to vessel formation. Expression of osteogenic markers was greater in the CO- than in the 
MSC-group. 
       Studies I & III demonstrated a significant effect of co-culture on osteogenesis. Systematic 
investigation continued in Study IV, namely microarray analysis with the HumanWG-6 v3.0 
expression BeadChips, each array representing >48,000 probes. A global map of gene 
expression after communication between MSC and EC was generated in a direct-contact 
model. Differentially expressed genes were identified and over-represented genes were 
annotated by gene ontology and biological processes and pathways. The results indicated that 
EC had a significant impact on MSC after 5 and 15 days. Of particular interest was the 
disclosure of bidirectional gene regulation of angiogenesis and osteogenesis through cell 
signaling, cell adhesion and cellular matrix. The results suggest that the cell-matrix interaction 
and the TGF-beta signal pathway might play a crucial role in EC-induced gene regulation of 
MSC. 
      The results of these studies thus support bone tissue engineering concepts based on 
seeding of MSC and EC onto copolymer scaffolding. Together, the cell culture and animal 
studies indicate that cross-communication between bone marrow stromal cells and endothelial 
cells has influenced the osteogenic differentiation as well as enhanced the bone healing.    
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1. Introductions 
There is a widespread need for appropriate bone substitutes that allow remodeling for bone 
defects or voids due to disease, trauma, or ablative surgery (Frohlich et al., 2008; Kneser et al., 
2006; Nakahara et al., 2009). Various limitations are associated with currently available 
therapies and the repair of critical-sized bone defects remains a challenge in the fields of 
implantology, maxillofacial surgery and orthopaedics (d'Aquino et al., 2009; Pollock et al., 
2008). Much research effort is being directed towards the development of bone tissue 
engineering techniques as alternatives to grafts for the treatment of bone defects.  
1.1 Bone Development and Remodeling 
Bone is a unique organ with the ability to remodel the volume of the skeleton continuously 
throughout life (Bilezikian et al., 2002 ; Hill, 1998; Urist, 1965). The initial stage of bone 
formation is the process of cellular condensation, whereby dispersed bone marrow stromal 
cells proliferate and differentiate into bone cells, which could be eventually bound together by 
the deposit of adhesion matrix (Bilezikian et al., 2002; Laugier et al., 1998; Meyer and 
Wiesmann, 2006).  
Subsequent bone development occurs via either intramembranous or endochondral 
ossification (Hill, 1998; Maniatopoulos et al., 1988; Urist, 1965). Intramembranous 
ossification with direct differentiation of mesenchymal stem cells into osteoblasts involves the 
replacement of connective tissue membrane sheets with bone tissue and results in the 
formation of flat bones (Bilezikian et al., 2002; Frohlich et al., 2008). Endochondral 
ossification involves the replacement of a hyaline cartilage framework with bone tissue 
(Meyer and Wiesmann, 2006). Both processes are closely regulated by coordinated 
expression and interaction of several molecules or pathways (Bilezikian et al., 2002; Frohlich 
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et al., 2008). The differentiation of mesenchymal cells into pre-osteoblasts is not well 
understood (Guillot et al., 2007; Kronenberg, 2003; Proff and Romer, 2009). 
Despite the differences between the two types of ossification, vascularization is a pre-
requisite for both (Bilezikian et al., 2002; Carano and Filvaroff, 2003; Hill, 1998; Santos and 
Reis, 2010; Towler, 2008). In intramembranous ossification there is an invasion of capillaries 
to transport mesenchymal stem cells. In endochondral ossification, the hypertrophic 
chondrocytes act as a template for bone formation, secreting angiogenic growth factors that 
promote the invasion of blood vessels, to replace the cartilage with bone and bone marrow 
(Canalis, 2009; Carano and Filvaroff, 2003). The vasculature also plays a crucial role in bone 
formation by the secretion of growth factors that will control the recruitment, proliferation, 
differentiation and function of bone-forming and bone-resorbing cells. Thus angiogenesis not 
only precedes osteogenesis but is also essential for its occurrence (McCarthy, 2006).  
1.2 Bone defects 
Bone defects or voids may result from disease, trauma, or ablative surgery. Concerning 
traumas, it is estimated that each year approximately 7.9 million bone fractures are sustained 
in the United States alone (Bishop and Einhorn, 2007; National Trauma Data Bank Report 
2005). Although most fractures heal uneventfully, between 5 and 10% of patients experience 
complications (Kneser et al., 2006; Termaat et al., 2005). Approximately one million fractures 
annually, at risk of delayed union or nonunion, require hospital care. Approximately 1.5 
million bone grafting operations are performed annually in the United States (Porter et al., 
2009; Surgeons, 2008). Hence there is a widespread need for appropriate bone substitutes that 
allow remodeling of native bone tissue. Various limitations are associated with currently 
available therapies and the repair of critical-sized bone defects and periodontal deep intrabony 
defects remains a challenge in the fields of regenerative periodontal therapy, implantology, 
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maxillofacial surgery and orthopaedics (d'Aquino et al., 2009; Pollock et al., 2008; 
Zafiropoulos et al., 2007).  
Current treatment options for bone defects   
Several treatment strategies are currently available for management of conditions requiring 
bone regeneration (Bilezikian et al., 2002; Finkemeier, 2002; Meyer and Wiesmann, 2006; 
Vaccaro et al., 2002; Zafiropoulos et al., 2007): autologous or allergenic bone, Xenografts, 
demineralized bone matrix, calcium phosphate-based bone graft substitute, distraction 
osteogenesis, or autologous bone marrow etc.  
Autologous bone grafts are regarded as the golden standard for bone regeneration. 
Conventional bone-grafting using autologous cortical and cancellous bone, harvested from the 
iliac crest, has been the standard against which all other bone-graft substitutes are assessed, 
but the method has some disadvantages (Frohlich et al., 2008; Kneser et al., 2006). Although 
there is no risk for immunogenic rejection with autogenous materials, the availability of bone 
for grafting is often limited (Meyer and Wiesmann, 2006). In cases of massive segmental 
bone loss, the autologous graft material available may be insufficient. Autogenous bone grafts 
may also have the potential disadvantage of a higher degree of resorption of the graft material 
(Zafiropoulos et al., 2007). Moreover, the harvesting procedure is associated with major 
complications in 8.6 % of cases and minor complications in 20.6 % (Finkemeier, 2002; 
Gazdag et al., 1995).  
Alternatives to autologous bone grafts such as allograft bone, demineralized bone matrix, 
distraction osteogenesis, recombinant growth factors and synthetic implants might possibly be 
combined with autologous bone marrow or various growth factors, but the current treatments 
could not meet the demanding clinical requirements (Vaccaro et al., 2002). Therefore, it is 
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important to have a variety of options available to augment, expand, or substitute for 
autologous bone grafts.  
The enormous clinical demand for treatment of bone defects has stimulated efforts to develop 
bone graft substitutes using the principles of bone tissue engineering (Kneser et al., 2006; 
Langer and Vacanti, 1993; Petite et al., 2000; Porter et al., 2009). While much work remains 
before this approach can be routinely applied in the clinical setting, increased understanding 
of bone physiology and advancements in biotechnology has led to a new surgical approach to 
control and modulate bone-healing (Termaat et al., 2005). 
1.3 Bone tissue engineering  
1.3.1 Definition 
The widely accepted definition of tissue engineering was stated in 1993 by Langer and 
Vacanti (Langer and Vacanti, 1993). The concept is based on an understanding of tissue 
formation and regeneration, and aims to induce new functional tissues, rather than just to 
implant new spare parts (Salgado et al., 2004). As shown in Figure 1, a tissue engineering 
construct has three main components (Meyer and Wiesmann, 2006): a scaffold, an 
osteoconductive matrix capable of supporting the bone cell ingrowth and differentiation; 
osteogenic cells (osteoblasts or osteoblast precursors), which in the proper environment are 
capable of forming bone and thirdly growth factors, which can stimulate and support 
mitogenesis of undifferentiated bone cells to form osteoprogenitor cells. 
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Scaffold
Osteogenic Cells Growth factors
Bone tissue engineering
Figure 1 The three major components of bone tissue engineering 
1.3.2 Scaffold 
The scaffold is crucial for successful engineering of bone tissues, providing a suitable 
environment in which osteogenic cells can migrate, proliferate, differentiate, and promote 
new bone formation. It also provides structural, mechanical support during bone regeneration 
(Frohlich et al., 2008). The fundamental concept underlying tissue engineering is the use of 
the body’s natural biological response to tissue damage in conjunction with engineering 
principles (Porter et al., 2009). In order to match the physiological needs of the bone tissues 
as it regenerates, an ideal scaffold must meet a number of demanding requirements: it must be 
biocompatible, biodegradable, promote cellular interactions and tissue development and have 
adequate mechanical and physical properties (Nair and Laurencin, 2007; Salgado et al., 2004).  
In response to the requirements for clinical application, a variety of bone scaffolding materials 
has been developed in recent years, including ceramics, polymers and their combinations. 
Ceramics such as hydroxyapaptite and tricalcium phosphate are biomaterials with good 
osteoconductivity and bone-bonding ability, but with limitation of poor degradability in a 
biological environment (Liu and Ma, 2004; Marcacci et al., 2007). In contrast, polymers 
exhibit flexibility of design and composition, allowing the structure to be tailored to specific 
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needs. The versatility of synthetic biodegradable polymers has led to  increasing interest in 
their potential application as scaffolding materials, enabling the fabrication of scaffolds with 
variations in such characteristics as form, porosity and pore size, degradation rates and 
mechanical properties (Karageorgiou and Kaplan, 2005; Nair and Laurencin, 2007).  
Polymers 
As FDA approved biomaterials, PLA and PCL have been acknowledged as potential 
candidates for tissue regeneration and used in a wide variety of clinical applications, such as 
sutures, systemic drug delivery, spinal fusion cages, coronary stents, and fixation screws (Liu 
and Ma, 2004; Mo et al., 2004; Rhee et al., 2004; Tang et al., 2005). In vivo, PLA and PCL 
are degraded through hydrolysis and enzymatic activity into their corresponding hydroxyl 
acids which are readily metabolized: thus these polymers are suitable as resorbable tissue 
engineering implant materials (Albertsson and Varma, 2003; Arvidson K et al., 2010; 
Dånmark et al., 2010; Meretoja et al., 2006; Odelius et al., 2008).  
Single monomers have specific properties and limited application. Given the highly specific 
biochemical and biomechanical requirements of each clinical application, it is unlikely that 
one single scaffolding material would prove optimal for all cases of tissue-engineered bone 
regeneration (Lofgren and Albertsson, 1994; Ryner and Albertsson, 2002). This can be 
compensated for by copolymerization with other monomers to generate copolymers which 
have greater versatility (Albertsson and Varma, 2003; Ryner and Albertsson, 2002; Sodergard 
and Stolt, 2002). Properties of polymers such as degradation rates and physical and 
mechanical properties can be improved and adjusted over a wide range by copolymerization 
(Odelius et al., 2005). In order to extend the potential areas of application of polymers, 
research effort is directed towards controlling the architecture and tailoring the properties of 
the materials to suit the intended application (Albertsson and Varma, 2003; Lofgren et al., 
1994; Mathisen and Albertsson, 1989).  
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Scaffold design 
In order to optimize integration into the surrounding tissues, scaffolds for osteogenesis should 
simulate bone morphology, structure and function. Several requirements need to be 
considered in the fabrication of 3D scaffolds. Firstly, an ideal bone scaffold should have 
sufficient porosity to accommodate bone cells (Finkemeier, 2002; Middleton and Tipton, 
2000; Srivastava and Albertsson, 2006). High interconnectivity between pores is also 
important for uniform cell seeding and distribution, the diffusion of nutrients to and transport 
of metabolites from the cell/scaffold constructs (Kyriakidou et al., 2008; Stiehler et al., 2009). 
Adequate mechanical stability is also important, to provide adequate support and protection 
before the new bone tissue has reached critical mechanical strength. In order to maintain the 
structural integrity, the degradation rate of the scaffolding must be tailored to match the rate 
of new bone formation (Edlund et al., 2008; Nair and Laurencin, 2007). The surface 
chemistry of the scaffold should be suitable for adhesion of bone cells. Finally, the 
scaffolding, while meeting all the above requirements, should also support the attachment, 
proliferation and differentiation of osteoblasts or osteoprogenitor cells and enhance bone 
regeneration (Liu and Ma, 2004; Salgado et al., 2004).  
It is of fundamental importance to document the response of osteogenic cells to polymers 
intended for tissue engineering applications. Most studies screening new scaffolds for in vivo
application have concerned the capacity to guide the infiltration of host cells and enhance 
bone regeneration (Bueno et al., 2007; Dånmark et al., 2010; Rouwkema et al., 2006). Also 
critical for optimization of conditions for bone tissue engineering, however, are in vitro
studies of the effects on matrix deposition and mineralization of such variables as cell-seeding 
density, culture period, scaffold architecture, scaffold composition, and cell source.  
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1.3.3 Osteogenic cells 
The goal of bone tissue engineering is the generation of new bone from osteogenic cells, 
supported by biocompatible, biodegradable, three-dimensional scaffolds (Guillot et al., 2007; 
Kneser et al., 2006). Osteogenic cells are an integral part of tissue engineering strategy, 
transplanted into the bone defect on the appropriate scaffolds or attracted from the host tissues 
by osteoinductive factors. Although the type of osteogenic cell most suitable for engineering 
of bone tissue has yet to be determined, bone marrow stromal cells are currently the main 
sources of osteogenic cells for research (Dånmark et al., 2010; Gulotta et al., 2009; Lozito et 
al., 2009; Oswald et al., 2004; Undale et al., 2009).  
Bone marrow stromal cells 
Bone marrow stromal cells (MSC), first revealed in plastic-adherence studies by Friedenstein 
et al (Friedenstein et al., 1968; Owen and Friedenstein, 1988), are regarded as the main source 
of bone progenitor cells in skeletal tissues. MSC derived from bone marrow are an obvious 
source of autologous osteogenic cells (Takagi and Urist, 1982). Of the cell types proposed for 
such application, MSC have several advantages (Undale et al., 2009). These multipotential 
stromal stem cells, located within the bone marrow, can differentiate into fibroblastic, 
osteogenic, adipogenic and reticular cells (Krebsbach et al., 1999; Lozito et al., 2009; Undale 
et al., 2009). Furthermore, these stem cells generate progenitors committed to one or more 
cell lines with an apparent degree of plasticity or interconversion. MSC are readily isolated 
from bone marrow and can be expanded in an in vitro culture system without loss of 
differentiation potential (Bilezikian et al., 2002). Under appropriate conditions, MSC can 
differentiate into osteocytes, chondrocytes, myocytes and neurons. In contrast to embryonic 
stem cells, there are no  associated ethical issues and MSC are widely applied in bone 
regeneration research, both in vitro and in vivo (Drost et al., 2009; Gulotta et al., 2009; 
Nakahara et al., 2009).  
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Although engraftment of human bone marrow stromal cells has been achieved, the long-term 
biological effects at the implant site and the question of cell plasticity have yet to be 
determined. A preliminary study has shown the therapeutic effects of human bone marrow 
derived osteoprogenitors transplanted into children with osteogenesis imperfecta (Horwitz et 
al., 2002), while clinical studies by Marcacci and co-workers illustrate the potential for 
autologous bone marrow stromal cells (with a porous bioceramic scaffold) in the treatment of 
large bone defects (Marcacci et al., 2007).  
Osteogenesis is a complicated process, influenced by physiological conditions, cell-to-cell 
interactions, extracellular matrix formation and vascularization. Previous studies have 
however, shown that MSC alone are unlikely to be sufficient for bone regeneration (Grellier 
et al., 2009; Guillotin et al., 2008; Kyriakidou et al., 2008; Yu et al., 2008).  
Endothelial cells 
Endothelial cells (EC) are essential to vasculogenesis: the process starts with the migration of 
endothelial cells or their progenitors (Jain, 2003). Endothelial cells are derived from the 
differentiation of mesodermal cells, which leads to the formation of the first vascular 
structures (Lamalice et al., 2007). These cells then give rise to the hematopoietic stem cells, 
which differentiate into angioblasts, the precursors of mature endothelial cells. Under the 
stimulation of vascular endothelial growth factor, the angioblasts and endothelial cells migrate 
on the extracellular matrix and remodel into tubular structures. Finally, these tubules form 
larger vessels (Bilezikian et al., 2002; Lamalice et al., 2007).  
In contrast to vasculogenesis, angiogenesis denotes the formation of new blood vessels from 
preexisting ones and is essential for bone healing and growth. Recent studies have begun 
exploring in detail the role of vascular endothelial cells and their products in bone physiology 
(Unger et al., 2007; Yu et al., 2009). These studies have disclosed that bone vascular 
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endothelial cells may participate in a complex communication network in bone, involving 
endothelial cells, osteoblasts, stromal cells, and perhaps other cell types found in bone. It 
appears that the interaction between endothelial and bone cells is regulated by multiple 
systemic and local signals which may be received, transduced, and integrated by individual 
cells. 
Interactions of MSC and EC 
In the context of the intricate relationship between angiogenesis and osteogenesis (Patel et al., 
2008), communication between MSC and EC is one of the most important cellular 
interactions for bone formation (Carano and Filvaroff, 2003; Towler, 2008). Several 
mechanisms are involved: interaction between membrane molecules of two adjacent cells 
(adherens and tight junctions); gap junction communications which form direct cytoplasmic 
connections; and secretion of diffusible factors from cells, or from the extracellular matrix 
(Grellier et al., 2009).  
It has been reported that EC co-cultured with MSC are able to establish microcapillary-like 
structures in a three dimensional spheroids (Rouwkema et al., 2006). Cells from different 
endothelial and osteoblastic lineages were used. The results showed that either differentiated 
endothelial cells or endothelial progenitor cells could be successfully co-cultured with 
different bone cells, sourced from primary osteoblasts harvested from bone fragments 
(Clarkin et al., 2008), the osteoblastic cell line MG63 (Unger et al., 2007), and bone marrow 
stromal cells (Kaigler et al., 2005). Previous studies indicated that EC could effect certain 
levels of osteogenesis, releasing bone morphogenetic proteins (Kaigler et al., 2005) and 
controlling the transcription factor Osterix for bone cell differentiation (Klinkner et al., 2006). 
Both MSC and endothelial expressed connexion 43 (Cx43), a specific gap junction protein 
(Villars et al., 2000; Villars et al., 2002). These two cell types can therefore communicate via 
a gap junctional channel, consisting of Cx43.  
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In support of these in vitro results, in vivo studies also showed the beneficial effect of tissue-
engineering constructs using bone cells and endothelial cells. In a rat bone defect model, co-
cultured EC and bone marrow-derived osteoblasts were implanted on PCL scaffolding: the 
results indicated not only improved osteogenesis but also enhanced vascularization (Nakahara 
et al., 2009). Co-cultured osteoblasts and endothelial cells within RGD-grafted alginate 
microspheres in a long bone defect of mice showed significantly enhanced mineralization of 
the microspheres in the co-culture group (Grellier et al., 2009). Taken together, the results of 
these studies indicate that endothelial cells can participate not only in osteogenic 
differentiation in vitro, but also in osteogenesis in vivo. These studies confirmed the intrinsic 
relationship between angiogenesis and osteogenesis (Figure 2): intercommunication between 
bone marrow stromal cells and endothelial cells was identified as one of the most important 
cellular interactions coordinating processes involved in bone formation.  
MSC Pre-osteoblast
ALP
Col I
Runx2
Osteoblast
Runx2
??
Osteogenic differentiation
EC 
Figure 2 The relationship between bone marrow stromal cells (MSC) and endothelial cells 
(EC). There are several stages of the differentiation of osteoblasts from MSC (Lian and Stein, 
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1992; 1995). However, the role of EC on the commitment of osteoblast is still not yet 
understood. 
1.3.4 Growth factors 
Growth factors can regulate the replication, differentiation, and function of bone cells 
(Canalis et al., 2003; Deckers et al., 2002). Although no growth factors are specifically 
synthesized by skeletal cells, they are expressed in a variety of tissues. Some, such as PDGF 
and FGF, display primarily mitogenic activity for cells of the osteoblastic lineage (Canalis et 
al., 2007; Canalis, 2009). Bone morphogenetic proteins (BMPs) and Wnt induce the 
differentiation of osteoblastic cells into mature osteoblasts (Canalis et al., 2003). The most 
extensively researched osteoinductive bone factors are BMPs, which belong to the 
transforming growth factor (TGF) beta superfamily (Canalis, 2009; Nesti et al., 2007; 
Termaat et al., 2005). Following extensive research, in 2002 and 2003 BMP2 and BMP7
respectively were approved by the FDA for use as alternatives to autografts (Canalis et al., 
2003; Deckers et al., 2002; Termaat et al., 2005). 
Studies on growth factors also indicated that the cross-communication between EC and 
osteoblasts is bidirectional. EC can secrete numerous regulatory molecules that play an 
important role in controlling bone-forming cells (Bouletreau et al., 2002; von Schroeder et al., 
2003; Wang et al., 1997), for example BMP2 and endothelian-1, which can promote 
osteoblastic proliferation and differentiation. On the other hand, one of the most well-
researched angiogenic factors, VEGF, can be produced at the fracture site by numerous cell 
types, including osteoblasts (Clarkin et al., 2008; Steinbrech et al., 2000; Street et al., 2002). 
Osteogenic growth factors produced by EC (BMP2, PDGF) and by osteoblasts (IGF, TGF) 
also have an angiogenic effect by inducing VEGF expression in osteoblasts (Deckers et al., 
2002; Goad et al., 1996). 
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1.3.5 Current challenges in bone tissue engineering  
A fully functional vascular network within bone-engineered constructs is crucial and remains 
a major challenge in bone tissue engineering (Grellier et al., 2009). After a bone construct is 
implanted in vivo, induction of initial vascularization is important: in particular, the survival 
of osteogenic cells in the interior of the scaffold is often threatened by the limited extent of 
initial vascularization (Kneser et al., 1999; Kneser et al., 2006). The implanted construct 
requires ongoing vascularization to ensure survival and integration, because it takes weeks for 
the host’s blood circulation to establish sufficient supply to the implant (Jain, 2003; Kaigler et 
al., 2006; McCarthy, 2006; Meyer and Wiesmann, 2006). Several strategies have been 
proposed to address this problem. For example, the addition of vascular cells such as 
endothelial cells might offer several advantages over seeding of osteogenic cells alone (Meyer 
and Wiesmann, 2006; Unger et al., 2007). However, the mode of communication between the 
bone cells and vascular cells, at the molecular level, has yet to be fully elucidated. 
In addition to addressing the limited blood supply for bone tissue engineering, the selection of 
an appropriate scaffolding to carry the cells and conditions at the cell-scaffold interface are 
also crucial determinants of successful clinical application.  
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2. Aims 
Bone tissue engineering is a promising strategy for reconstruction/ regeneration of skeletal 
defects. However, insufficient blood supply after implantation remains a major obstacle to 
clinical success. The overall aims of the studies on which this thesis is based were to explore 
the interactions between bone marrow stromal cells and endothelial cells to identify possible 
biological pathways involved in the repair of bone defects. The studies were undertaken in 
order to contribute towards the development of an appropriate tissue engineered construct, 
comprising cells seeded onto biodegradable copolymer scaffolds.  
         The specific aims of the individual studies were: 
• To investigate whether direct communication between bone marrow stromal cells and 
endothelial cells could influence the osteogenic differentiation of bone marrow 
stromal cells. 
• To evaluate the initial cellular attachment, proliferation, and differentiation of bone 
marrow stromal cells onto scaffolds made of (poly(LLA-co-CL)), (poly(LLA-co-
DXO)) and poly(L-Lactide). 
• To determine the effect on bone regeneration of co-culturing endothelial cells and 
bone marrow stromal cells onto a poly(LLA-co-DXO) scaffold in a rat calvarial defect 
model. 
• To identify possible biological pathways after co-culture of bone marrow stromal cells 
and endothelial cells and to determine the subsequent patterns of global gene 
expression, using microarray gene expression profiling. 
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3. Materials and Methods 
A brief outline of the entire project is presented in Figure 3.  
Figure 3.  A brief outline of the whole study 
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The various experimental models, evaluations and methods are briefly summarized in Table 1. 
A more detailed description is provided in the individual papers (I-IV).   
Table 1 Summary of the methods used 
Experimental models Evaluations Methods Paper 
In vitro mono-culture (MSC) 
and co-culture (MSC/EC) on 
two dimensional (culture plate)
Cell Morphology 
Cell proliferation 
Gene profiling 
SEM, Immunostaining 
SEM, WST-1 
PCR, Superarray 
I 
MSC cultured on 3D scaffolds 
made of: 
Poly(LLA-co-CL) 
poly(LLA-co-DXO) 
poly(LLA) (control) 
Cell Morphology 
Cell proliferation 
Gene profiling 
SEM 
SEM, WST-1 
PCR 
II 
Rat calvarial defect model 
Bone regeneration 
Vessel Formation 
Gene profiling 
X-ray 
Histological analysis 
PCR 
III 
MSC/EC and MSC 
on culture plate 
Global gene profiling 
Validation 
Microarray 
• SAM 
• GO Classification 
• pathways 
PCR 
IV 
3.1 Scaffold design and fabrication (Paper II) 
Copolymer poly(LLA-co-CL) and poly(LLA-co-DXO) were synthesized as described 
recently (Dånmark et al., 2010). Porous scaffolds were produced from the copolymers 
poly(LLA-co-CL) and poly(LLA-co-DXO) by a solvent-casting-particulate-leaching method. 
The pore size was greater than 90 µm and the porosity 90 %. Porous scaffolds of poly(LLA) 
were synthesized in the same way to serve as three dimensional (3D) controls.  
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3.2 In vitro studies 
3.2.1 Cell culture (Paper I, II and IV) 
Primary human MSC (StemCell Technologies, Vancouver, BC, Canada) were cultured in 
MesenCult® complete medium according to the manufacturer’s instructions. Primary human 
umbilical vein endothelial cells were obtained from Lonza (Clonetics®, Walkersville, MD) 
and were expanded in EGM® Medium containing 500 ml of Endothelial Cell Basal Medium 
and the following growth supplements: BBE, 2 ml; hEGF, 0.5 ml; hydrocortisone, 0.5 ml; 
FBS, 10 ml; GA-1000, 0.5 ml.  
EC and MSC were trypsinized separately and then co-cultured at a ratio of 1:5 in a mixed, 
osteogenic factor-free medium. MSC were also grown alone in both osteogenic and 
osteogenic factor-free medium. The culture medium was changed after 3 days.  
In study II, MSC were seeded at a density of 1 × 105 cells/disc onto polymer discs which fitted 
into the wells of a 48-well plate.  
3.2.2 Morphological evaluation 
Immunostaining (Paper I)
Cells grown on Ø 18 mm coverslips were rinsed in phosphate buffered saline (PBS) and fixed 
with 4% paraformaldehyde for 15 min. In order to distinguish the two cell types, MSC were 
labelled with CD90 and EC with Lectin Tritc-UEA I. The nuclei were stained with DAPI 
solution and the samples were examined by fluorescence microscopy. 
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Scanning Electron Microscopy (Paper I and II) 
The samples were rinsed in 2.5% glutaraldehyde in PBS and fixed for 30 min and then fixed 
in 2.5% glutaraldehyde in 0.1 M Na-cacodylate PH 7.2 with 0.1 M sucrose for a further 30 
min. The samples were treated with 1% osmium tetroxide in distilled water for 1h, followed 
by dehydration through a graded series. Critical point drying was carried out and the samples 
were coated with a 10 nm conducting layer of gold platinum and examined in the scanning 
electron microscope at a voltage of 10 kV. 
3.2.3 Cell viability and proliferation tests (Paper I and II) 
Cell proliferation and viability were analyzed by colorimetric assay for quantification of 
cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenases in viable cells. The 
cells were incubated for a further 12 h at 37C with 100 µl medium containing 10 µl WST-1 
reagents. The samples were shaken for 1 min and absorbance at 450 nm was measured by a 
microplate spectrophotometer.  
3.2.4 Gene profiling  
Real-time PCR  
Total RNA was isolated from cell cultures using Trizol® reagent combined with E.Z.N.A.TM 
Tissue RNA isolation kit. The reverse transcription reaction test was undertaken using the 
High Capacity cDNA Archive Kit. Quantitative RT-PCR was conducted on a StepOne system, 
using TaqMan gene expression assays. 6 ng of mRNA was used in each PCR reaction and 
mixtures were made up in 10µl triplicates for each target cDNA. The data were analysed by 
the relative standard curve method. GAPDH served as an endogenous control. 
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RT2 Profiler PCR Array of osteogenesis (Paper I) 
Contamination of genomic DNA was removed from total RNA samples by DNase I digestion 
prior to first-strand synthesis. cDNA synthesis was performed with the RT2 PCR array First 
Strand Kit. Human Osteogenesis RT2 Profiler PCR Array and RT2 Real-time SyBR 
Green/ROX PCR Mix were purchased from SuperArray Bioscience Corporation. The Ct 
method was used for data analysis, and each gene fold-change was calculated as the 
difference in gene expression between co- and mono-cultured MSC.  
3.2.5 Statistical analysis 
All in vitro experiments were repeated at least three times using MSC from 3 separate donors 
and pooled human EC. The data were expressed as mean ± SD for minimum n=3. The data 
were tested for normal distribution and variance homogeneity, using one-way ANOVA. 
Differences between means were considered statistically significant when p<0.05. For 
statistical analysis, SPSS 15.0 software was used. 
3.3 In vivo study (Paper III) 
3.3.1 Isolation, induction and characterization of rat cells 
MSC were isolated from the femurs of donor Lewis rats and the marrow cavity was flushed 
with -MEM supplemented 15 % fetal bovine serum into a sterile falcon tube. The cells were 
resuspended and plated in culture flasks in -MEM containing 10% FBS.  At harvest, 1/5 of 
MSC were induced to EC in Endothelial Cell Growth Medium-2 using methods described 
previously (Yu et al., 2009). The remaining MSC were cultured in freshly prepared 
osteogenic stimulatory medium, containing dexamethasone, ascorbic acid and -
glycerophosphate. EC were characterized of CD31 and Flk-1 by flow cytometry.   
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3.3.2 Graft Preparation and surgical implantation 
Poly(LLA-co-DXO) scaffolds were pre-wet with the culture media overnight. Either MSC 
alone (MSC-group), or both cell types (CO-group) were seeded onto the scaffold. The 
cell/scaffold grafts were incubated overnight and then transferred to spinner flasks for 1 week 
before surgery. Before implantation, CO/scaffold constructs cultured in spinner flasks were 
retrieved and Alexa Fluor® 568 conjugated isolectin GS-IB4 was used to reveal EC 
distribution and to identify any in vitro formation of capillary-like structures. 
Symmetrical bone defects, 6 mm in diameter, were created in the parietal part of the calvaria 
in 12 animals. Either MSC-group or CO-group constructs were implanted on random sides of 
9 animals. In three animals serving as controls, one side was implanted with unseeded 
scaffolds only (Scaffold-group) and the other side was left untreated (Empty-group). After 8 
weeks the animals were sacrificed. The scaffolds were carefully dissected out and 
immediately frozen.  
3.3.3 Radiographic and histological analysis 
Radiographs of the retrieved parts of the skull from each rat were taken using a dental X-ray 
machine under exposure conditions of 10 mA, 0.08 ms and 70 KV. The exposed films were 
processed and the digital images were analyzed with software NIS-Elements BR.  
The specimens for histological examination were fixed with 4 % paraformaldehyde and 
decalcified for four weeks. The specimens were embedded and then cryosectioned to 8 µm 
thickness. The sections were stained with Masson’s Trichrome method to confirm the osteoid 
areas. Image analysis was performed; a common threshold was defined to include the entire 
osteoid area by software NIS-Elements. Isolectin GS-IB4 was applied to disclose vessel 
formation in the graft area.  
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3.3.4 Statistical Analysis 
SigmaStat 3.1 was applied for statistical processing and analysis. Two-group comparison 
(MSC- and CO-groups) was carried out by paired t-test and significant differences were set as 
p<0.05. All values in the bar diagrams were presented as mean ± standard deviation. 
3.4 Microarray study (Paper IV) 
3.4.1 Experimental Design 
The experiments used six different individual MSC treated with mixed EC at a ratio of 5:1 in 
a mixed, osteogenic factor-free medium. MSC were grown alone as a control. After 5 and 15 
days’ cultivation, EC were removed from co-culture by addition of 2 ml trypsin for 5 min, 
followed by washing with PBS. The cells were finally rinsed again with 2 ml trypsin for 
another 5 min at 37°C. MSC were retrieved from both co-culture and the control group.  
3.4.2 Sample preparation  
Total RNA from 5- and 15-day cultures was isolated using an E.Z.N.A.TM Tissue RNA 
isolation kit. In this study, samples with a RIN value of at least 7.5 were selected. 250 ng of 
total RNA was reversely transcribed, amplified and labelled, using the Illumina TotalPrep 
RNA Amplification Kit. The amount and quality of Biotin-labelled cRNA were controlled 
and 1500 ng cRNA was hybridized at 58˚C for 17 hours. The iScan Reader software extracts 
signal intensities and saves all files for each BeadChip.  The data from the scanning of arrays 
was investigated in GenomeStudio and J-Express 2009 as quality control measures. The 
SampleProbeProfile was loaded in to J-Express as two separate experiments (5 and 15 days) 
and further quality control of the data was undertaken. 
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3.4.3 Microarray Data Analysis  
In the microarray data analysis, it was assumed that the majority of genes would behave 
similarly, irrespective of how they had been treated and that only a few genes would have 
been altered by treatment. These distributions need to be similar for the different samples to 
be comparable, as shown in Figure 4. 
Figure 4 Hierarchical Clustering of 5-day samples. In the 5-day experiment, hierarchical 
clustering of normalized data using Pearson Correlation as a measure of distance, revealed 
two main clusters, corresponding to the co-culture (T) and control (C) groups, indicating 
differential expression of genes between the two groups at the global level  
To identify genes differentially expressed between two groups, significance analysis of 
microarrays (SAM) method (Tusher et al., 2001) was undertaken using J-express software. 
Since a donor-paired group was used in this experiment, gene expression measurements were 
analysed by a paired SAM method. Changes in the gene-expression profile were identified at 
an estimated false discovery rate of less than 1%. Genes with a fold-change greater than 2 
were selected. Differentially expressed genes were mapped to a gene ontology (GO) directed 
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acyclic graph in J-express 2.9 and compared with the total number of genes, to determine 
over-representation of GO terms. 
To classify each cluster in more detail according to their ontological properties, lists of 
overrepresented genes from the SAM test were submitted to the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) (Dennis et al., 2003; Huang et al., 2009). 
The Gene Functional Classification tool in DAVID builds clusters of genes with significantly 
similar ontology, as tested against the whole list of genes in the Human Genome array. A 
similar analysis was performed with the genes against a reference list of genes through the 
DAVID bioinformatics database, which is a classification system (http://www.DAVID.org/) 
for identifying overrepresented biological processes and key pathways. 
3.4.4 Validation of microarray data by RT-PCR 
To validate the microarray data, real time PCR was undertaken on up- and down-regulated 
genes. Amplification was carried out in 96-well thermal cycle plates using a StepOne 
detection system. Gene expression was determined by the comparative Ct method, 
normalizing expression to the reference gene GADPH. For quantitative RT-PCR, the 
difference between groups was assessed using ANOVA, with statistical significance set at p < 
0.05.  
3.5 Ethical approvals 
The study protocols of the in vitro studies (225.05) and the protocols for the animal 
experiments (project no. 2006290-31/07/2006, 20091572) were approved by Ethics 
Committee at Bergen University. The animal procedures were conducted in accordance with 
Norwegian and European Union (EU) animal safety regulations. 
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4. Results and Discussions 
4.1 Direct Cell-to-cell communication (Paper I) 
The present studies were designed using a 1:5 (EC:MSC) cell mix for 5 days of culture. 
Different EC:MSC ratios had been co-cultured in pilot studies and it was found that EC could 
grow well and exist as a continuous stimulatory factor for MSC in the 1:5 ratio, which closely 
simulates in vivo conditions (Meyer, 2006). The SEM and immunostaining results (Figure 5) 
indicated that there might be communication between the two cell types after 5 days of 
culture.  
Figure 5 Morphology of cell communications between co-cultured MSC and EC: SEM 
showing morphology of EC after 5 days (a); SEM of MSC and EC after 5 days (b); cellular 
bridge between MSC and EC disclosed by SEM (c) and by immunostaining (d).  
In the early stages of osteoblast-mediated mineralization, bone ALP is considered to have an 
important function in the removal of inorganic pyrophosphate, a potent inhibitor of 
mineralization (Sharp and Magnusson, 2008). ALP is often used as a biochemical and 
histochemical marker for identification and evaluation of osteogenesis. Interestingly, there 
was an almost 5-fold increase in ALP expression when MSC were co-cultured with EC at less 
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than 20% of the total cell population. This increase was confirmed by both Superarray and 
PCR evaluation of cells cultured in osteogenic factor-free medium. Furthermore, the PCR 
results showed that after 5 days of co-culture, the effect induced by EC was greater than that 
induced by osteogenic stimulatory medium.  
However, co-culturing of MSC with EC did not influence Runx2 expression. It has been 
shown that Runx2 plays a role in the commitment-step to osteo-chondro progenitor cells 
(Komori et al., 1997; Nakashima et al., 2002; Otto et al., 1997; Phillips et al., 2006). The 
findings indicated that up-regulation of ALP might be independent of Runx2. However, the 
identification of other potential pathways will require further investigation. On the other hand, 
the low level of bone gamma-carboxyglutamate protein (BGLAP) expressed by MSC 
suggests that it is unlikely that such immature cells would have the potential to undergo 
terminal differentiation within 5 days of co-culture with EC. Therefore, EC could direct MSC 
to the early stage of osteogenic cells. The Superarray test disclosed that the genes related to 
chondrocyte differentiation (Sox 9, MMP2, FGF2) (Bilezikian et al., 2002; Jin et al., 2007) 
were down-regulated, suggesting that EC might provide important signals for chondrocytic 
differentiation and have an important influence on chondrocyte commitment and maturation.  
4.2 Evaluation of three different polymeric scaffolds (Paper II) 
To select a copolymer scaffold appropriate for carrying cells, bone marrow stromal cells were 
seeded onto two porous scaffolding materials, poly(LLA-co-CL) and poly(LLA-co-DXO).  
The cellular responses were investigated in terms of attachment, proliferation and 
differentiation.  
At 1 h post-seeding, SEM disclosed earlier cell-spreading on poly(LLA-co-DXO) and 
poly(LLA-co-CL) than on poly(LLA) scaffolds, which served as controls. At 24 h and 14 
days post-seeding, MSCs in all groups showed spreading morphology and multilayers of cells 
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on the scaffolds. The more rapid attachment of MSC after 1 h to poly(LLA-co-DXO) and 
poly(LLA-co-CL) than to poly(LLA) scaffolds might be attributable to a relative 
improvement in hydrophilicity or other properties as a result of copolymerization. DXO is a 
sticky, wax-like amorphous polymer without any stability of form, but when used as a co-
monomer it increases both the hydrophilicity and the degradation rate (Dånmark et al., 2010; 
Odelius et al., 2008). Caprolactone (CL) is tough, flexible and semicrystalline and it is 
permeable to low molecular weight species at body temperature. However, associated with 
the hydrophobicity of CL is the disadvantage of a slow degradation rate, which needs to be 
enhanced by copolymerization with other suitable monomers (Holmbom et al., 2005; Kim et 
al., 2004; Meretoja et al., 2006; Rhee et al., 2004). 
Cell viability and proliferation, assessed by microscopy and WST-1 assay, indicated better 
proliferation on poly(LLA-co-DXO) and poly(LLA-co-CL) than on poly(LLA) after  different 
incubation times. This might be explained by earlier attachment of MSC to poly(LLA-co-
DXO) and poly(LLA-co-CL) than to poly(LLA) scaffolding. During the process of cell 
seeding, more rapid attachment of cells to scaffolds could enhance cell survival and accelerate 
tissue ingrowth (Bueno et al., 2007). Compared with a tissue culture plate, the porous 
scaffolds provide much greater surface areas for cell seeding and spreading. The spatial 
distribution of human MSC on a scaffold is quite different from that on tissue culture plates.  
After the induction of osteogenic factors (dexamethasone, ascorbic acid and -
glycerophosphate), MSC in all the groups expressed the specific bone markers ALP, Runx2, 
Col I and OPN. This indicated that poly(LLA-co-DXO), poly(LLA-co-CL) and poly(LLA) 
could support the osteogenic differentiation of MSC in vitro; in this respect, there were no 
significant differences among the three scaffolding materials. However, the results showed 
that cells grown on tissue culture plates exhibited greater expression of ALP, Col I and Runx2 
by MSC than the cells on the scaffolds.  
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With respect to cell attachment, proliferation and differentiation, all the results indicated that 
these newly developed copolymers are promising candidates as scaffolding material for bone 
tissue engineering. 
4.3 Effect of endothelial cells on bone regeneration (Paper III) 
As shown in Study I, endothelial cells might influence the differentiation of bone marrow 
stromal cells. Therefore, the aim of this study was to evaluate this effect in vivo, using a rat 
calvarial bone defect model. Either MSC alone (MSC-group) or co-cultured EC/MSC (CO-
group) were seeded onto poly(LLA-co-DXO) scaffolds, cultured in spinner flasks and then 
implanted into symmetrical calvarial defects prepared in recipient rats. To investigate vessel 
formation, histological staining was performed with EC markers after 2 months.  
After co-culture of EC and MSC in a spinner flask for one week, the EC had spontaneously 
organized into typical vessel-like structures. These findings suggest that under dynamic 
culture conditions, prevascularization could be achieved to enhance bone regenerative 
potential before implantation.  
The bioreactor is an important factor in the formation of a functional construct (Martin et al., 
2004; Stiehler et al., 2009). The cell/scaffold constructs must be cultured in an environment 
with sufficient nutrient and mechanical properties to induce cell phenotypes and activity. 
Stiehler and co-workers has shown that compared with static culture, dynamic 3-D culture in 
a spinner flask could achieve better proliferation, distribution and differentiation of human 
bone marrow stromal cells (Stiehler et al., 2009). 
Gross observation of retrieved samples showed varying stages of healing. In the Empty-group, 
the defects were covered by a thin layer of soft tissue. The defects in the other groups were 
totally filled with the implanted grafts. There was no gross evidence of serious inflammation, 
infection or necrosis. Radiographic and histological examination showed more rapid bone 
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formation in the CO- than in the MSC-group (Figure 6). However, histological analysis 2 
months postoperatively showed similar expression of EC markers in both groups. 
Furthermore, RT-PCR demonstrated that the CO-group exhibited greater expression of 
osteogenic markers.  
Figure 6. X-ray results from different groups: very few high density areas were visible in the 
Empty, Scaffold and MSC-groups. (A) CO-group showed visibly higher density than the other 
groups. (B) Image analysis showed significantly higher intensity from the CO  than the MSC-
group. 
In vivo studies using co-culture have demonstrated improved bone regeneration, but 
contradictory results for vascularization (Kaigler et al., 2006; Yu et al., 2009). The present 
study showed no statistically significant differences between the MSC- and the CO-groups 
with respect to vascularization of the implanted grafts two months postoperatively. Thus the 
question of whether transplanted EC could have a further effect on angiogenesis in the 
recipient animal remains unresolved. In order to improve our understanding of angiogenesis 
in promoting osteogenesis in a tissue engineered bone reconstruction model, further research 
is needed on interactions between endothelium and osteogenic cell phenotypes. 
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4.4 Changes in global gene expression (Paper IV) 
Based on the findings of studies I & III, demonstrating the effect on osteogenesis of co-
culturing EC with MSC, further systematic investigation was carried out using microarray 
analysis. The HumanWG-6 v3.0 expression BeadChips, with each array representing >48,000 
probes was used and a global map of gene expression following cell interactions between 
MSC and EC was generated in a direct-contact model.  
A map was generated of differentially expressed genes of MSC after co-culture with EC for 5 
and 15 days. The map disclosed complex bidirectional gene regulation mechanisms between 
MSC and EC. Although the top 20 gene list could only display partially differentiated genes, 
it could indicate the most significant changes after co-culture. Genes related to angiogenesis 
were upregulated by MSC after co-culture. Meanwhile, markers of osteogenesis, such as ALP, 
FKBP5 (Liu et al., 2007) and BMP were also up-regulated in the cocultured-MSC. 
Importantly, this finding might provide the basis of an alternative strategy for simultaneously 
improving angiogenesis and osteogenesis in engineered bone constructs: further investigation 
of the molecular interactions between the two cell types might provide new insights into 
mesenchymal stem cell biology. 
Interaction between the two cell types involved not only cell-cell communication but also cell 
adhesion and cell-ECM communication. Among the top up-regulated genes is another 
important group, namely ECM related genes such as CD 93, CDH5, VWF, and MMRN1. 
This trend was also found in the cluster analysis. In the 5-day-experiment, GO clustering 
(Table 2) disclosed obvious effects on signal peptide (98 genes), cell adhesion (28 genes), 
extracellular matrix (27 genes), blood vessel development (18 genes), cell migration (17 
genes) and ECM-receptor interaction (10 genes). The studies also indicated that EC-matrix 
contained certain signals and factors which could modify MSC differentiation into EC. 
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Table 2 Gene Ontology annotation of overrepresented gene lists by DAVID
5-day GO term Annotation 
GO Term Count P Value Fold Enrichment Bonferroni FDR Enrichment Score
Signal peptide 98 1.16E-21 2.628575622 1.09E-18 1.82E-18 17.6667 
Cell adhesion 28 7.02E-13 5.657907013 2.30E-10 9.51E-10 10.1803 
Extracellular matrix 27 3.16E-12 5.450620082 6.35E-10 3.96E-09 9.15492 
Blood vessel development 18 6.57E-08 5.183016488 1.08E-04 1.10E-04 6.70772 
Cell migration 17 1.72E-06 4.362624794 0.00281331 0.002885 5.19 
Response to wounding 22 9.51E-06 3.059008886 0.01546976 0.015965 3.64 
Immunoglobulin domain 19 9.94E-06 3.469646478 0.00324597 0.01346 3..29 
Hydroxylation 9 1.28E-06 11.21025606 4.20E-04 0.001737 3.22 
EGF-like region, conserved site 17 1.35E-06 4.471613194 6.35E-04 0.001922 2.94 
Chelation 4 8.97E-05 41.72706422 0.02889946 0.121339 2.83 
Mesenchymal cell development 6 6.81E-04 8.439014025 0.67289333 1.137838 2.8 
ECM-receptor interaction 10 1.36E-05 6.643437863 9.96E-04 0.014244 2.58 
Domain:CTCK 4 0.00262892 14.25152905 0.91444934 4.039053 2.45 
Response to organic substance 25 6.09E-05 2.480940351 0.09505084 0.102228 2.37 
Regulation of locomotion 11 3.08E-04 4.168493974 0.39663103 0.516048 2.27 
Prostaglandin receptor activity 3 0.00613438 24.53757225 0.90757121 8.186742 2.15 
Urogenital system development 8 9.76E-04 5.087869325 0.79827397 1.626004 2.07 
C-type lectin-like 7 0.00145361 5.6740638 0.49671796 2.05637 2.02 
Tube development 10 0.00335422 3.29450998 0.99595457 5.486517 1.99 
IL 17 Signaling Pathway 4 0.00518607 10.43809524 0.34712179 5.40332 1.9 
It is well known that the TGF-beta pathway is important for osteogenesis differentiation and 
cell proliferation (Nesti et al., 2007). Bone matrix is one of the richest reservoirs of TGF-beta 
and osteoblasts possess several different TGF-beta receptors (Nesti et al., 2007). In the 5-day 
treatment group, 7 genes were recruited into this pathway (Figure 7). All theses genes are 
contributed most of the path of genes interaction, and the consequences of the interaction are 
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the osteoblast differentiation and cell cycle in Figure 7. This finding tends to support and 
explain the results of Study I, such as increases in bone markers (ALP, Col I) and positive 
effects on proliferation. The results suggest that EC could direct mesenchymal stem cells 
towards the osteoblastic phenotype and be considered as osteoinductive mediators in a co-
culture model (Grellier et al., 2009) TGF-beta pathway suppression might explain why only 
early stage bone markers were detected by the microarray test.   
Figure 7 TGF-beta signaling pathway:    Labeling showed 19 differentiated genes in the map
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5. Conclusions
• In the absence of osteogenic factors, co-culture of bone marrow stromal cells with 
endothelial cells induced the expression of ALP after a short incubation time (5 days). 
ALP expression by bone marrow stromal cells in co-culture was even higher than that 
achieved by the addition of osteogenic stimulatory medium: this effect seems to be 
independent of Runx2. 
• Co-culture of endothelial and bone marrow stromal cells on poly(LLA-co-DXO) 
scaffolding implanted in rat calvarial defects enhanced the osteogenic potential and 
induced more rapid bone formation.  
• The microarray study generated a global map of gene expression of the interaction 
between bone marrow stromal cells and endothelial cells. Endothelial cells had a 
significant impact on bone marrow stromal cells after 5 and 15 days, especially with 
respect to cell signal, cell adhesion and cellular matrix formation. 
• TGF-beta as a key biological pathway is crucial for endothelial cell-induced osteogenic 
gene regulation in bone marrow stromal cells. 
• Human bone marrow stromal cells showed consistently better attachment and growth on 
scaffolds made of poly(LLA-co-DXO) and poly(LLA-co-CL) than on poly(LLA) 
scaffolds.  This suggests that these newly developed copolymers may be promising 
candidates as scaffolding material for bone tissue engineering. 
Future Perspectives 
Many challenges remain before bone tissue engineering can be applied in the clinical setting. 
The co-culture model is mimicking of natural bone and results contribute to understanding of 
bone physiology and treatment strategies. The present study is based on only 5:1 MSC/EC, 
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and the addition of less than 20% endothelial cells to bone marrow stromal cells could 
enhance early osteogenic differentiation and increase bone regeneration. Global gene profiling 
indicates that several signals and biological pathways are involved in cell-to-cell 
communication. The finding of bidirectional gene regulation of angiogenesis and osteogenesis 
in co-culture offers potentially new approaches in tissue engineering by modulating bone-
healing through cell-to-cell interactions. Functional studies are warranted to explore and 
understand the interaction between bone and endothelial cells, using in vitro and large animal 
experiments.   
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